9000180009900198009900198001080021600
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

9000180009900198009900198001080021600
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
Myeloid tumors with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1 were classified as a new type of myeloid neoplasm in the 2008 WHO classification of myeloproliferative neoplasms (MPN) based on clinical presentation and drug sensitivity;
Individuals in this group are sensitive to tyrosine kinase inhibitor therapy and have a high rate of complete remission after treatment.